Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes
about
The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptorsEvaluation of benzyltetrahydroisoquinolines as ligands for neuronal nicotinic acetylcholine receptorsInside-out neuropharmacology of nicotinic drugsCrystal Structure of Lymnaea stagnalis AChBP Complexed with the Potent nAChR Antagonist DHβE Suggests a Unique Mode of AntagonismCreating an 7 Nicotinic Acetylcholine Recognition Domain from the Acetylcholine-binding Protein: CRYSTALLOGRAPHIC AND LIGAND SELECTIVITY ANALYSESAlzheimer's disease: Targeting the Cholinergic SystemPrinciples of agonist recognition in Cys-loop receptorsThe habenulo-interpeduncular pathway in nicotine aversion and withdrawalIdentification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptorsQuantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampusNicotine receptor subtype-specific effects on auditory evoked oscillations and potentialsSecreted Isoform of Human Lynx1 (SLURP-2): Spatial Structure and Pharmacology of Interactions with Different Types of Acetylcholine ReceptorsCellular, molecular, and genetic substrates underlying the impact of nicotine on learning.Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways.The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.Spontaneous nicotine withdrawal potentiates the effects of stress in ratsModulation of hippocampus-dependent learning and synaptic plasticity by nicotine.The binding orientation of epibatidine at α7 nACh receptorsMouse model predicts effects of smoking and varenicline on event-related potentials in humans.α7β2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their α7-α7 interfaces.Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptors.Ligand-induced conformational change in the alpha7 nicotinic receptor ligand binding domainChemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes.In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRsNicotinic and muscarinic acetylcholine receptors shape ganglion cell response properties.Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine.Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals.Effects of benzothiazepines on human neuronal nicotinic receptors expressed in Xenopus oocytes.Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.Interactions of atropine with heterologously expressed and native alpha 3 subunit-containing nicotinic acetylcholine receptorsalpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells.Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.Pharmacology of nicotinic receptors in preBötzinger complex that mediate modulation of respiratory pattern.Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferentsNicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.Revisiting the effect of nicotine on interval timing.Characterizing functional α6β2 nicotinic acetylcholine receptors in vitro: mutant β2 subunits improve membrane expression, and fluorescent proteins reveal responsive cells.
P2860
Q24651488-4BD4793D-51C3-416F-BD22-AC1F52B7C6EDQ24670461-5E27FA35-5E3F-41CB-B8D9-C6F7E40910C5Q27010347-3E48D875-2A75-42C9-B52B-930ECE2B25B2Q27671732-23AFB808-6A51-48B5-9580-17D8BC1FA32FQ27675116-EDF31813-5EAF-4A66-AA23-FDA65D713A3AQ28070135-904B1C82-AE65-4664-8CDE-BA881E817EA0Q28239408-1D6FF0A0-A7D6-4018-A36B-8E3EFAD850B9Q28253308-2EEC32BE-F829-4943-A82B-3D10DE533A4AQ28477118-EB9567B4-DB7D-4449-9545-BE09A97A6A32Q28579460-5A622E92-9DC6-426C-86E4-5AF03AC0F42BQ28728978-A9B5F5D8-50A2-4A3E-B1F0-CF33E713DEBAQ29871448-C5AB416D-42E3-49A3-AD93-3E5BC46A8D9EQ30422037-47E15543-4A53-443D-9A84-057D36D55C71Q30432387-7207394F-F90E-4FFB-A053-0BEC460B5388Q30486732-6BC8DB02-059C-4440-AF71-266DB6DFA32DQ30487853-3A8A954E-E6FF-4BBC-9FC1-77C699DE2F22Q30489625-64F8C1E1-7FFC-462D-8CFA-7D5DE5F7EF99Q33561991-B63D4477-7665-44E3-8174-0383CE673121Q33885925-CF498C5A-7B83-4495-8EFC-210F003C3016Q34062025-277E3F3B-BFE7-47A4-A0DD-1D9355F642C5Q34127939-28684143-C93A-4A57-BB9A-4A9CC7847FD2Q34189724-6B004418-3215-4C6E-B2C0-D4ABF7F06EB6Q34215376-C9B21E26-6B7B-4F94-85AF-61836AF40006Q34239996-B617D0FB-F242-4073-9EF0-725EB2D3DD54Q34249682-2B09EAD3-73CB-45E5-A447-43B728659196Q34340033-83CBD991-D728-4FFD-8CDE-BE9B8C274144Q34387101-912C9FFA-36ED-4FF4-8C08-A5B76AE5B927Q34959443-54F6CF4E-D630-4ECB-BAB9-27195E8148AFQ34961709-49FB0AE7-9923-4A8E-8A6D-148CE949401BQ35042018-06B02965-F169-4584-A480-7B25950790BCQ35044348-C1EDF60E-B637-4567-B22F-F2355E628EF5Q35044540-C319BD5F-6BD3-414E-8A2F-D76902B4CF5DQ35045059-EAC661A6-B00D-4060-B944-ED30D8A71CDDQ35070760-79A74736-2F7D-4FC6-B3A1-69893974F82FQ35095077-2E5A2071-87C0-4A4E-BD3C-3FCF4154AFACQ35111894-BB53EB0A-01DB-4A5D-B13E-6DA05AC8F484Q35117646-C0F78FAB-E4FA-42C5-963A-EA1F941031ACQ35142884-E36C5EDD-5A3C-4457-B4A5-A3F72B71F0EDQ35152211-7B6E7555-9DF6-47EB-A7AD-E82066CEFEDBQ35182023-EC471125-1F5E-48F8-A3D1-6E7ACC353DA1
P2860
Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@ast
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@en
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@nl
type
label
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@ast
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@en
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@nl
prefLabel
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@ast
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@en
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@nl
P2093
P3181
P1476
Pharmacological characterizati ...... 7 expressed in Xenopus oocytes
@en
P2093
E C Johnson
K J Elliott
L E Chavez-Noriega
M S Washburn
P304
P3181
P407
P577
1997-01-01T00:00:00Z